C1S

China Shineway Pharmaceutical Group Limited (C1S)

Market Open
16 Jun, 06:01
XMUN XMUN
0. 87
0
0%
- Market Cap
7.19 P/E Ratio
0.48% Div Yield
0 Volume
0 Eps
0.87
Previous Close
Day Range
0.87 0.87
Year Range
0.83 1.28
Earnings results expected in 70 days

Summary

C1S trading today higher at €0.87, an increase of 0% from yesterday's close, completing a monthly increase of 2.37% or €0.02. Over the past 12 months, C1S stock lost -24.78%.
C1S is not paying dividends to its shareholders.
The last earnings report, released on Mar 28, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Aug 27, 2025.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on XFRA (EUR).
Want to track C1S and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

C1S Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.

China Shineway Pharmaceutical Group Limited Dividends

C1S
C1S 1 month ago
Other
€0.33 Per Share
C1S
C1S 9 months ago
Other
€0.1 Per Share
C1S
C1S 29 Apr 2024
Other
€0.4 Per Share
C1S
C1S 12 Sep 2023
Other
€0.1 Per Share
C1S
C1S 28 Apr 2023
Other
€0.31 Per Share

China Shineway Pharmaceutical Group Limited Earnings

27 Aug 2025 (70 Days) Date
-
Cons. EPS
-
EPS
28 Mar 2025 Date
-
Cons. EPS
-
EPS
26 Mar 2025 Date
-
Cons. EPS
-
EPS
29 Aug 2024 Date
-
Cons. EPS
-
EPS
28 Aug 2024 Date
-
Cons. EPS
-
EPS
C1S
C1S 1 month ago
Other
€0.33 Per Share
C1S
C1S 9 months ago
Other
€0.1 Per Share
C1S
C1S 29 Apr 2024
Other
€0.4 Per Share
C1S
C1S 12 Sep 2023
Other
€0.1 Per Share
C1S
C1S 28 Apr 2023
Other
€0.31 Per Share
27 Aug 2025 (70 Days) Date
-
Cons. EPS
-
EPS
28 Mar 2025 Date
-
Cons. EPS
-
EPS
26 Mar 2025 Date
-
Cons. EPS
-
EPS
29 Aug 2024 Date
-
Cons. EPS
-
EPS
28 Aug 2024 Date
-
Cons. EPS
-
EPS

China Shineway Pharmaceutical Group Limited (C1S) FAQ

What is the stock price today?

The current price is €0.87.

On which exchange is it traded?

China Shineway Pharmaceutical Group Limited is listed on XFRA.

What is its stock symbol?

The ticker symbol is C1S.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Aug 27, 2025.

Has China Shineway Pharmaceutical Group Limited ever had a stock split?

No, there has never been a stock split.

China Shineway Pharmaceutical Group Limited Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Zhenjiang Li CEO
XMUN Exchange
KYG2110P1000 ISIN
CN Country
3,220 Employees
30 Apr 2025 Last Dividend
- Last Split
- IPO Date

Overview

China Shineway Pharmaceutical Group Limited operates as an investment holding entity primarily focused on the research, development, manufacturing, and trading of Chinese medicines. Established in 2002 and headquartered in Shijiazhuang, within the People’s Republic of China, it has cemented its presence in both the local Chinese market and Hong Kong. The company’s commitment to enhancing traditional Chinese medicine (TCM) is reflected through its wide range of product offerings and its expansion into various therapeutic domains. As a subsidiary of Forway Investment Limited, China Shineway Pharmaceutical continues to explore innovative solutions within the TCM industry, alongside its engagement in the trading of agricultural products, marking its diversified interests and business model adaptation to the evolving market needs and opportunities.

Products and Services

  • Soft Capsules:

    China Shineway Pharmaceutical has developed a range of soft capsules aimed at treating various health conditions. These capsules are designed to provide patients with an easy-to-consume form of traditional Chinese medicine, focusing on improving user compliance and medication absorption.

  • Granules:

    As part of its product lineup, the company offers granules, another popular form of traditional Chinese medicine. These granules are tailored for specific health conditions, providing a precise dosage that ensures effectiveness while maintaining the integrity of traditional medicinal practices.

  • Injections:

    In addition to oral formulations, China Shineway Pharmaceutical produces injections derived from TCM ingredients. These injections target severe or acute conditions, offering a potent and direct therapeutic effect that is critical for certain types of diseases and patients.

  • TCM Formula Granules:

    The company has also specialized in TCM formula granules, which encompass a variety of therapeutic areas such as respiratory, digestive, cardiovascular, and cerebrovascular diseases, orthopedics, pediatrics, and nervous system disorders. These formula granules are designed for the specific needs of different patient groups, focusing on both curing and preventing diseases with roots in TCM philosophy.

  • Medication for Strengthening the Body:

    Beyond treating specific ailments, China Shineway Pharmaceutical offers medications aimed at strengthening the body's immune system and overall health. These products are grounded in the preventive aspect of traditional Chinese medicine, emphasizing wellness and the promotion of long-term health.

  • Agricultural Products Trading:

    Expanding its business horizon, the company engages in the trading of agricultural products. This diversification reflects its strategic adaptation to market trends and its endeavor to leverage the extensive network and expertise developed through its core operations in pharmaceuticals.

Contact Information

Address: No. 168 Shiluan Street
Phone: 86 31 1880 30066